Economy/Home · Economy

HLB Pharmaceutical Finalizes Paid-In Capital Increase Issue Price at 5,650 Won... 10,762,332 New Shares to Be Issued

HLB Pharmaceutical has finalized the final issue price of new shares from its paid-in capital increase at 5,650 won per share. The shares to be issued through this capital increase are 10,762,332 registered common shares. According to a regulatory filing on the 8th, the first-stage issue price was

Oseong Kwon
Staff Reporter
3 min read
HLB Pharmaceutical Finalizes Paid-In Capital Increase Issue Price at 5,650 Won... 10,762,332 New Shares to Be Issued
CBC News

HLB Pharmaceutical has finalized the final issue price of new shares from its paid-in capital increase at 5,650 won per share. The shares to be issued through this capital increase are 10,762,332 registered common shares.

According to a regulatory filing on the 8th, the first-stage issue price was calculated at 5,650 won and the second-stage issue price at 5,710 won. The company set the final issue price at 5,650 won based on the lower of the two prices, among other criteria. The par value per share is 500 won, and the issue price determination date is September 7, 2026.

A 25% discount rate was applied in calculating the issue price. The first-stage issue price was calculated based on the volume-weighted average stock price from the reference date, which was the third trading day before the new share allocation reference date, and the closing price on that date. The second-stage issue price was calculated using the third trading day before the first day of existing shareholders' subscription as the reference date.

The finalized issue price is determined by applying the lower of the first- and second-stage issue prices. However, in accordance with relevant regulations, if the price is lower than the one calculated by applying a 40% discount rate to the volume-weighted average stock price during the period from the third to the fifth trading day before the subscription date, that price applies instead. The same finalized issue price applied to existing shareholders' subscription also applies to the general public offering issue price.

Oseong Kwon
Staff Reporter

CBC Globe publishes verified stories with editorial review, source checks, and tenant-specific publication standards.